[ad_1]
The company has threatened to retaliate after a person who participated in the Covid vaccine trial conducted by the Serum Institute in India sent a legal notice to the company seeking Rs 5 crore in damages.
The man who took the legal action against the Serum Institute is a resident of Chennai, South India, who claimed that he became seriously ill after being vaccinated on October 1.
The legal notice he sent said that the company had assured him that the Kovid vaccine was “completely safe.” As a result, he assumed that the tick had no side effects.
The wife of the 40-year-old man told The Hindu that her husband participated in the trial out of a “desire to serve the people.”
But now they are demanding to stop the testing and production of that Serum Institute ticker.
His lawyer, Rajaram, said the man had been suffering from severe headaches since he was vaccinated and could not answer any questions.
He also suffered from “acute neuroencephalopathy,” the lawyer said.
Meanwhile, as soon as news of the legal notice reached the media, the Serum Institute of India said in a press release Sunday night that the person’s claim was ‘completely malicious’ and the information provided by him as well. it was completely false.
The statement further said that a contrary case will be brought against the person demanding compensation of more than 100 million rupees.
A copy of the legal notice has already been sent to the Comptroller General of Drugs of India. They have also launched a separate investigation into the matter.
It is worth mentioning that the University of Oxford in the United Kingdom and the pharmaceutical company AstraZeneca have signed an agreement with the Serum Institute of India for the industrial production of the covid vaccine.
The Pune-based company is the world’s largest vaccine manufacturer by number or dose and is now conducting a phase III trial of that Oxford-invented covid vaccine.
As part of the trial, the author was given a trial injection of the vaccine last month at the Sriramchandra Institute in Chennai.
When he became ill after the vaccination, he was treated at the same institution. Now that it has filed a formal complaint on the matter, the institute has also conducted its own investigation into the matter.
The chief investigator on behalf of the organization. SR Ramakrishnan says: ‘After being admitted to the hospital, the man recovered very quickly. We have assumed all the costs of your treatment.
“He has undergone follow-up treatment here and we know that he is fine now,” the lead doctor told BBC Bangla.
But the man’s family has stated on the charge sheet that his physical condition is not yet stable.
He suffers from “mood swings” and has difficulty performing simple daily routine tasks, according to the legal notice.
In the past, many vaccine trials have been conducted in India, but this kind of legal battle between a participating organization and an organization that manufactures vaccines is unprecedented.
However, India’s drug controller has yet to issue a stay of the ongoing trial over the allegations.
But if it has any effect on the trial, it is closely watched by all concerned.
Beximco Pharmaceuticals of Bangladesh has also signed an agreement with the Serum Institute of India to purchase the covid vaccine. As a result, they are naturally involved in their own interests.
Source: BBC
[ad_2]
